| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1877 | 2020 |
| Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival TR Halfdanarson, KG Rabe, J Rubin, GM Petersen Annals of oncology 19 (10), 1727-1733, 2008 | 993 | 2008 |
| Treatment-related adverse events of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis Y Wang, S Zhou, F Yang, X Qi, X Wang, X Guan, C Shen, N Duma, ... JAMA oncology 5 (7), 1008-1019, 2019 | 689 | 2019 |
| Hematologic manifestations of celiac disease TR Halfdanarson, MR Litzow, JA Murray Blood 109 (2), 412-421, 2007 | 526 | 2007 |
| Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors TR Halfdanarson, J Rubin, MB Farnell, CS Grant, GM Petersen Endocrine-related cancer 15 (2), 409, 2008 | 480 | 2008 |
| Neuroendocrine tumors, version 1.2015 MH Kulke, MH Shah, AB Benson, E Bergsland, JD Berlin, LS Blaszkowsky, ... Journal of the National Comprehensive Cancer Network 13 (1), 78-108, 2015 | 411 | 2015 |
| Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline/locally advanced pancreatic cancer MJ Truty, ML Kendrick, DM Nagorney, RL Smoot, SP Cleary, RP Graham, ... Annals of surgery 273 (2), 341-349, 2021 | 363 | 2021 |
| Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology MH Shah, WS Goldner, AB Benson, E Bergsland, LS Blaszkowsky, ... Journal of the National Comprehensive Cancer Network 19 (7), 839-868, 2021 | 361 | 2021 |
| Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial JL Welsh, BA Wagner, TJ Van’t Erve, PS Zehr, DJ Berg, TR Halfdanarson, ... Cancer chemotherapy and pharmacology 71, 765-775, 2013 | 349 | 2013 |
| NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018 MH Shah, WS Goldner, TR Halfdanarson, E Bergsland, JD Berlin, ... Journal of the National Comprehensive Cancer Network 16 (6), 693-702, 2018 | 341 | 2018 |
| Hematological manifestations of copper deficiency: a retrospective review TR Halfdanarson, N Kumar, CY Li, RL Phyliky, WJ Hogan European journal of haematology 80 (6), 523-531, 2008 | 322 | 2008 |
| The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors JR Strosberg, TR Halfdanarson, AM Bellizzi, JA Chan, JS Dillon, ... Pancreas 46 (6), 707-714, 2017 | 306 | 2017 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 304 | 2021 |
| The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors JR Howe, NB Merchant, C Conrad, XM Keutgen, J Hallet, JA Drebin, ... Pancreas 49 (1), 1-33, 2020 | 302 | 2020 |
| A single-institution experience with 491 cases of small bowel adenocarcinoma TR Halfdanarson, RR McWilliams, JH Donohue, JF Quevedo The American journal of surgery 199 (6), 797-803, 2010 | 259 | 2010 |
| Radiofrequency ablation versus stereotactic body radiotherapy for localized hepatocellular carcinoma in nonsurgically managed patients: analysis of the national cancer database DJ Rajyaguru, AJ Borgert, AL Smith, RM Thomes, PD Conway, ... Journal of Clinical Oncology 36 (6), 600-608, 2018 | 195 | 2018 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 183 | 2021 |
| Colorectal cancer-review S Haraldsdottir, HM Einarsdottir, A Smaradottir, A Gunnlaugsson, ... Laeknabladid 100 (2), 75-82, 2014 | 177 | 2014 |
| Oncologic emergencies: diagnosis and treatment TR Halfdanarson, WJ Hogan, TJ Moynihan Mayo Clinic Proceedings 81 (6), 835-848, 2006 | 154 | 2006 |
| Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ... Cancer discovery 10 (10), 1514-1527, 2020 | 142 | 2020 |